2017年 11月 10日
EMERGO SUMMARY OF KEY POINTS:
As cybersecurity vulnerabilities become a more urgent concern for the medical device industry, encryption requirements are emerging as a key tool to address medical device cybersecurity concerns. In the US, compliance with the FIPS 140-2 standard can help manufacturers of network-connected devices and software demonstrate encryption capabilities able to protect patient and user data.
Below, we cover several common questions about the role of FIPS 140-2 and related encryption practices in medical device companies’ cybersecurity management efforts.
First, encryption is generally defined as a secret transformation of data utilizing an encryption key to convert readable data into illegible form; encryption conceals data to prevent its exposure, theft or misuse.
In the realm of medical devices, encryption is necessary to protect patient privacy and safety. To this end, the US FDA has published medical device premarket and post-market cybersecurity guidance that recommend using encryption to ensure secure data transmissions to and from networked devices.
FIPS 140-2 is a US Federal Information Publication Standard issued by the National Institute of Science and Technology (NIST); FIPS 140-2 specifically defines the quality of cryptography, and lays out requirements for implementation of encryption capabilities in devices and other products. These requirements are intended to ensure protection of data when the device is at rest and when data is being received by or sent from the device.
For a device manufacturer, FIPS 140-2 compliance would be one way to demonstrate encryption capabilities that many purchasers such as hospitals and clinics require. The US Veterans Health Administration (VA), for example, requires FIOS 140-2 compliance for all medical devices and software that transmit data via wireless technologies. Given that the VA is one of the biggest healthcare product procurers in the US, FIPS 140-2 compliance is not optional for any device manufacturer or developer seeking business with the agency.
Medical device manufacturers seeking to attain FIPS 140-2 compliance should consider the following factors:
Although US regulators do not yet outright require FIPS 140-2 compliance for registrants with wireless or networked devices, companies should expect more FDA attention to these issues as cybersecurity becomes a larger focus.
“The FDA has written several Additional Information (AI) letters in response to new 510(k) premarket notification submissions for network-connected products requesting more data on applicants’ software quality and security,” says Laura Élan, Practice Leader, Digital Health and Cybersecurity at UL.
Élan adds that more and more purchasing organizations at hospitals and other large healthcare providers are asking for detailed evidence that manufacturers are addressing security including encryption capabilities in their offerings.